Literature DB >> 17989159

Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria.

Arthur Chun-Wing Lau1, Mary Sau-Man Ip, Christopher Kei-Wai Lai, Kah-Lin Choo, Kam-Shing Tang, Loretta Yin-Chun Yam, Moira Chan-Yeung.   

Abstract

PURPOSES: To estimate the prevalence of undiagnosed airflow obstruction (AFO) in Hong Kong smokers with no previous diagnosis of respiratory disease, and to assess its variability when applying different prediction equations and diagnostic criteria.
METHODS: A multicenter, population-based, cross-sectional prevalence study was performed in smokers aged 20 to 80 years. Three different criteria (fixed 70% [Global Initiative for Chronic Obstructive Lung Disease and British Thoracic Society], fixed 75%, and European Respiratory Society [ERS]) were applied to define a lower limit of normal (LLN) of the FEV(1)/FVC ratio to compare with the Hong Kong Chinese reference equation (criterion 1), which had used a distribution-free method to obtain the lower fifth percentile of FEV(1)/FVC ratio as the LLN.
RESULTS: In 525 male patients, using criterion 1 (local internal prediction equation) and defining AFO as FEV(1)/FVC less than LLN, the overall prevalence of AFO was 13.7%: 8.3% in age > or = 20 to 40 years, 14.0% in age > or = 40 to 60 years, and 17.8% in age > or = 60 to 80 years. When the local internal prediction equation was used as the comparison reference, the fixed-ratio methods tended to miss AFO in younger age groups and overdiagnose AFO in old age, while the ERS criteria, which uses an almost lower fifth percentile-equivalent method, showed less of such a trend but still only showed moderate agreement with criterion 1.
CONCLUSIONS: Undiagnosed AFO was prevalent in Hong Kong smokers. Estimated prevalence rates were highly affected by the criteria used to define AFO. The predicted lower fifth percentile values calculated from a local reference equation as the LLN of FEV(1)/FVC ratio should be used for the diagnosis of AFO.

Entities:  

Mesh:

Year:  2007        PMID: 17989159     DOI: 10.1378/chest.07-1434

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

Review 2.  What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?

Authors:  Nitin Y Bhatt; Karen L Wood
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  How appropriate is the gold standard for diagnosis of airway obstruction?

Authors:  Ashutosh N Aggarwal
Journal:  Lung India       Date:  2008-10

4.  Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD.

Authors:  Bernd Lamprecht; Lea Schirnhofer; Bernhard Kaiser; Sonia A Buist; David M Mannino; Michael Studnicka
Journal:  Pulm Med       Date:  2011-02-06

5.  Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).

Authors:  Wai Cho Yu; Sau Nga Fu; Emily Lai-Bun Tai; Yiu Cheong Yeung; Kwok Chu Kwong; Yui Chang; Cheuk Ming Tam; Yuk Kwan Yiu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-08-26

6.  Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong - computerized data collection and analysis.

Authors:  Hok Sum Chan; Fanny Wai San Ko; Johnny Wai Man Chan; Loletta Kit Ying So; David Chi Leung Lam; Veronica Lee Chan; Cheuk Yin Tam; Wai Cho Yu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-13

Review 7.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

8.  Lymphocyte Apoptosis in Smokers and Non-Smokers Following Different Intensity of Exercises and Relation with Lactate.

Authors:  Kyung-Shin Park; Yang Lee
Journal:  Int J Exerc Sci       Date:  2011-07-15

9.  CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers.

Authors:  David Chi-Leung Lam; Hoi-Hin Kwok; Wai-Cho Yu; Fanny Wai-San Ko; Cheuk-Yin Tam; Arthur Chun-Wing Lau; Daniel Yee-Tak Fong; Mary Sau-Man Ip
Journal:  BMC Pulm Med       Date:  2018-03-16       Impact factor: 3.317

10.  Defining obstructive ventilatory defect in 2015.

Authors:  Zied Affes; Salaheddine Rekik; Helmi Ben Saad
Journal:  Libyan J Med       Date:  2015-10-08       Impact factor: 1.743

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.